NNVC - NanoViricides, Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical NNVC - NanoViricides, Inc.

Previous 10 Next 10

To: donpat who wrote (849)	1/9/2006 10:54:57 AM
From: Kulnor	of 12870

Sweet news :-) What's the stop transfer story?

Share	RecommendKeepReply Mark as Last Read Read Replies (2)

To: donpat who wrote (849)	1/9/2006 11:29:32 AM
From: donpat	of 12870

==Dr. Seymour added, "Our system is also perfectly suited to deal with certain potential bioweapon viruses such as Ebola and Marburg. To our knowledge, we have a major head start in the area of targeted anti-viral therapies.== Virus profiles: library.thinkquest.org Nasty things. Hopefully we will zap 'em all.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Kulnor who wrote (850)	1/9/2006 11:40:31 AM
From: donpat	of 12870

'stop transfer' - I know nothing.

Share	RecommendKeepReply Mark as Last Read

From: Becky	1/9/2006 12:17:11 PM
	of 12870

$1.49 WOW!! What a run! Now, ,,, the pullback.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Becky who wrote (853)	1/9/2006 1:09:20 PM
From: rrm_bcnu	of 12870

Becky, As long as the news remains company favorable on the litigation, I suspect a pullback may not occur as in the past spike. This news is just too hot to warrant selling. rrm

Share	RecommendKeepReply Mark as Last Read

To: donpat who wrote (851)	1/9/2006 1:58:57 PM
From: donpat	of 12870

Epstein-Barr Hantavirus Hepatitis Herpes HIV Influenza Marburg / Ebola Measles Polio Rabies Rubella Smallpox Yellow Fever Plenty of prospects. This is a work in progress. Onward and upward.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: donpat who wrote (855)	1/9/2006 3:47:34 PM
From: jmhollen	of 12870

Yo, dp, ...How many times does $0.09 go into $1.45...??? I forgot. ...I'm only used to those "..high-dollar Snob Stocks.." that occasionally go up 7%-12% or so annually.... John :-) .

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: jmhollen who wrote (856)	1/9/2006 5:41:15 PM
From: donpat	of 12870

You .09 - me .20! But at $200 - who really cares! It is going to $200, you know. And when it gets there...know what will happen? ....................(fill in the blank!) Believe. I do. Now...let me think...200/.20=1000 bagger - at least the math is easy. I always admired Google and watched it soar from the sidelines - it's so much more invigorating to own the race horse. And pass Google. ;-)

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: donpat who wrote (857)	1/9/2006 6:16:42 PM
From: Becky	of 12870

Donpat: How long do you think it'll take to get to $200.00? How about $20? ;>)

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

From: Becky	1/9/2006 6:24:35 PM
	of 12870

Helloo? What the HECK is this? From today's press release... "The Company will be seeking official and judicial relief as well as seek monetary damages for the harm caused to the Company." Does anyone understand this? "The Company has issued a "stop transfer" on approximately 3.8 million shares and options held by a former officer and the individuals involved with the "shell company" Edotcom.com, prior to its merger with NanoViricides. The Company will be seeking official and judicial relief as well as seek monetary damages for the harm caused to the Company. The Company will update its shareholders in a separate press release on this matter to be released within the coming days. These actions will help the Company complete its audit and become a reporting company. It is management's goal to meet the requirements necessary to be listed on a major exchange. ABOUT NANOVIRICIDES, INC

Share	RecommendKeepReply Mark as Last Read Read Replies (1)